BIO5 member Clara Curiel-Lewandrowski and colleagues are developing synthetic wavelength imaging, a noninvasive optical technology to visualize skin cancers with greater depth and clarity. Supported by a $2.7M NIH award, the team aims to improve diagnosis and treatment precision.